Skip to Content

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in New Drug Approvals

FDA Approves Inrebic (fedratinib) for the Treatment of Patients With Myelofibrosis

(BUSINESS WIRE)-- Celgene Corporation (NASDAQ: CELG) today announced the U.S. Food and Drug Administration (FDA) has approved Inrebic (fedratinib) for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis.1 “The approval of Inrebic is another...

Posted today in Medical

Exercise Your Blues Away

Exercise is good medicine for depression, researchers report. "The evidence of the use of physical activity and exercise for the management of depression is substantial and growing fast," said study authors Felipe Barretto Schuch, from Federal University of Santa Maria in Brazil, and Brendon Stubbs, from King's College London. "Despite this substantial...

Posted today in Medical

FDA Approves Inrebic Capsules for Myelofibrosis

Inrebic (fedratinib) capsules have been approved to treat adults with intermediate-2 or high-risk primary or secondary myelofibrosis, making it the second drug approved to treat patients with this disease, the U.S. Food and Drug Administration announced today. Approval of Inrebic for patients with intermediate-2 or high-risk primary or secondary (post-polycythemia...

Posted yesterday in New Drug Approvals

FDA Approves Rozlytrek (entrectinib) for People With ROS1-Positive, Metastatic Non-Small Cell Lung Cancer and NTRK Gene Fusion-Positive Solid Tumors

August 15, 2019 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Rozlytrek (entrectinib) for the treatment of adults with ROS1-positive, metastatic non-small cell lung cancer (NSCLC). The FDA has also granted accelerated approval to Rozlytrek for the...

Posted yesterday in New Drug Approvals

FDA Approves Wakix (pitolisant), a First-in-Class Medication for the Treatment of Excessive Daytime Sleepiness in Adult Patients with Narcolepsy

PLYMOUTH MEETING, PA, August 15, 2019 — Harmony Biosciences, LLC (Harmony) announced today that the U.S. Food and Drug Administration (FDA) approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy. Wakix is the first and only treatment approved for patients with narcolepsy that is not...

Posted 2 days ago in FDA Alerts

Pfizer Inc. Issues a Voluntary Nationwide Recall for 2 Lots of Relpax (eletriptan hydrobromide) 40 mg Tablets Due to Potential Microbiological Contamination of Non-Sterile Products

Pfizer Inc. is voluntarily recalling Relpax (eletriptan hydrobromide) 40 mg tablets, lots AR5407 and CD4565, to the Patient level. Pfizer Inc. initiated this recall because these product lots may not meet Pfizer’s in-house microbiological specification for the potential presence of Genus Pseudomonas and Burkholderia. Individuals who consume oral...

Posted today in News for Health Professionals

Pediatric Cannabis Exposure Up After Medical Legalization

Following medical marijuana legalization (MML) in Massachusetts in 2012, there was an increase in pediatric cannabis exposure, according to a study published online Aug. 16 in JAMA Network Open. Jennifer M. Whitehill, Ph.D., from the University of Massachusetts Amherst, and colleagues compared pediatric cannabis exposure cases before and after MML in...

Posted today in News for Health Professionals

Cases of Severe Lung Injury After Vaping Reported in Three States

Four cases of severe lung injury possibly linked with vaping in Minnesota are similar to dozens of cases in Wisconsin and Illinois. The patients had symptoms such as shortness of breath, fever, cough, vomiting, diarrhea, headache, dizziness, and chest pain, and some were hospitalized for "multiple weeks, with some patients being admitted to the intensive...

Posted today in New Drug Approvals

FDA Approves Rinvoq (upadacitinib), an Oral JAK Inhibitor for the Treatment of Moderate to Severe Rheumatoid Arthritis

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Rinvoq (upadacitinib), a 15 mg, once-daily oral Janus kinase (JAK) inhibitor, for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response...

Posted today in Medical

5 Health Tips to Promote Back-to-School Success

Healthy kids do better in school -- something parents need to think about as they prepare for a new academic year. "As a parent and grandparent, I know that back-to-school time is a busy time. Yet, I encourage parents and students to be mindful of some health essentials to add to your to-do lists," said Dr. Robert Redfield, director of the U.S. Centers...

Read more news...

Recently added consumer and prescribing information: Nubeqa, Baqsimi, Xpovio, Vyleesi, Slynd, Piqray, Nayzilam, Qternmet XR, Skyrizi, Balversa

Posted in Blog

Your Medicine Is Polluting Our Environment

Doctors prescribe medicines to treat a disease, correct a deficiency, or prevent a condition from happening. For example, beta blockers help lower blood pressure, iron tablets correct iron deficiency, and birth control pills prevent pregnancy. We take our prescribed medication as directed (or sometimes we don’t!) and expect it to do what it is meant […]

Posted in Blog

Green Gold

The signing of the 2018 Farm Bill by Trump in December last year paved the way for a more widespread (yet still restricted) cultivation of hemp and a more regulated cannabidiol (CBD) market. And that market is currently booming, with a forecasted revenue of over 22 million by 2022. But there is still a lot […]

Posted in Blog

Worshipping The Wine (or Beer) God or Godess

For many Americans, alcohol is a big part of their life. No matter the occasion, from weddings to birthday parties, family gatherings to date nights, most assume alcohol will be available. In fact, more than 50% of people say they would enjoy a major event less if alcohol was prohibited. But at what point does […]

See more blog posts or follow us on twitter.